A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

Such other conditions may include hypertension, heart problems, chronic kidney disease and diabetes mellitus. There is a ...

Living with diabetes requires proactive lifestyle management. A balanced diet, regular exercise, and avoiding alcohol and ...